On Wednesday, in Medtronic Inc. v. Mirowski Family Ventures LLC, the U.S. Supreme Court unanimously reversed the U.S. Court of Appeals for the Federal Circuit in a declaratory judgment case brought by Medtronic to challenge the validity of a patent on which it was paying licensing royalties. The Federal Circuit had held that Medtronic, as the licensee, had the burden of proving its products did not infringe the licensed patent. But the S...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In